David Toung
Stock Analyst at Argus Research
(3.41)
# 910
Out of 4,846 analysts
120
Total ratings
63.44%
Success rate
10.27%
Average return
Main Sectors:
Stocks Rated by David Toung
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TMO Thermo Fisher Scientific | Maintains: Buy | $620 → $470 | $396.47 | +18.55% | 7 | Apr 29, 2025 | |
| UNH UnitedHealth Group | Downgrades: Hold | n/a | $304.72 | - | 8 | Apr 21, 2025 | |
| IART Integra LifeSciences Holdings | Upgrades: Buy | n/a | $12.31 | - | 2 | Mar 31, 2025 | |
| ELV Elevance Health | Reiterates: Hold | $405 | $377.05 | +7.52% | 1 | Jan 29, 2025 | |
| ABBV AbbVie | Upgrades: Buy | n/a | $186.99 | - | 6 | Nov 4, 2024 | |
| CAH Cardinal Health | Maintains: Buy | $115 → $125 | $155.25 | -19.48% | 9 | Sep 11, 2024 | |
| CRL Charles River Laboratories International | Downgrades: Hold | n/a | $135.04 | - | 5 | Jun 28, 2024 | |
| AMGN Amgen | Maintains: Buy | $300 → $340 | $288.47 | +17.86% | 10 | Jun 27, 2024 | |
| MCK McKesson | Maintains: Buy | $570 → $670 | $721.75 | -7.17% | 6 | Jun 24, 2024 | |
| ZBH Zimmer Biomet Holdings | Upgrades: Buy | $150 | $91.11 | +64.64% | 7 | May 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $770 → $840 | $747.12 | +12.43% | 3 | May 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $89 → $95 | $62.01 | +53.20% | 1 | May 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $80 → $110 | $70.15 | +56.81% | 1 | Apr 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | n/a | $247.85 | - | 1 | Mar 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $23.46 | - | 1 | Mar 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $231.39 | - | 8 | Mar 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $285 → $310 | $380.86 | -18.61% | 2 | May 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $285 → $310 | $382.16 | -18.88% | 2 | May 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $265 → $320 | $553.29 | -42.16% | 3 | Dec 22, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $150 → $135 | $133.57 | +1.07% | 4 | Jul 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $75 | $108.91 | -31.14% | 5 | Jan 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $48.79 | - | 4 | Nov 1, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $110 | $76.25 | +44.26% | 3 | Nov 1, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $150 → $165 | $83.74 | +97.04% | 6 | Aug 27, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $6.87 | - | 1 | Aug 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $110 → $123 | $48.61 | +152.01% | 3 | Jun 18, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $71.93 | - | 4 | Apr 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $116.70 | - | 3 | Mar 10, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $165 → $155 | $155.40 | -0.26% | 4 | Mar 27, 2020 |
Thermo Fisher Scientific
Apr 29, 2025
Maintains: Buy
Price Target: $620 → $470
Current: $396.47
Upside: +18.55%
UnitedHealth Group
Apr 21, 2025
Downgrades: Hold
Price Target: n/a
Current: $304.72
Upside: -
Integra LifeSciences Holdings
Mar 31, 2025
Upgrades: Buy
Price Target: n/a
Current: $12.31
Upside: -
Elevance Health
Jan 29, 2025
Reiterates: Hold
Price Target: $405
Current: $377.05
Upside: +7.52%
AbbVie
Nov 4, 2024
Upgrades: Buy
Price Target: n/a
Current: $186.99
Upside: -
Cardinal Health
Sep 11, 2024
Maintains: Buy
Price Target: $115 → $125
Current: $155.25
Upside: -19.48%
Charles River Laboratories International
Jun 28, 2024
Downgrades: Hold
Price Target: n/a
Current: $135.04
Upside: -
Amgen
Jun 27, 2024
Maintains: Buy
Price Target: $300 → $340
Current: $288.47
Upside: +17.86%
McKesson
Jun 24, 2024
Maintains: Buy
Price Target: $570 → $670
Current: $721.75
Upside: -7.17%
Zimmer Biomet Holdings
May 21, 2024
Upgrades: Buy
Price Target: $150
Current: $91.11
Upside: +64.64%
May 14, 2024
Maintains: Buy
Price Target: $770 → $840
Current: $747.12
Upside: +12.43%
May 9, 2024
Maintains: Buy
Price Target: $89 → $95
Current: $62.01
Upside: +53.20%
Apr 1, 2024
Maintains: Buy
Price Target: $80 → $110
Current: $70.15
Upside: +56.81%
Mar 25, 2024
Upgrades: Buy
Price Target: n/a
Current: $247.85
Upside: -
Mar 22, 2024
Downgrades: Hold
Price Target: n/a
Current: $23.46
Upside: -
Mar 13, 2024
Downgrades: Hold
Price Target: n/a
Current: $231.39
Upside: -
May 25, 2023
Maintains: Buy
Price Target: $285 → $310
Current: $380.86
Upside: -18.61%
May 10, 2023
Maintains: Buy
Price Target: $285 → $310
Current: $382.16
Upside: -18.88%
Dec 22, 2022
Maintains: Buy
Price Target: $265 → $320
Current: $553.29
Upside: -42.16%
Jul 28, 2022
Maintains: Buy
Price Target: $150 → $135
Current: $133.57
Upside: +1.07%
Jan 28, 2022
Upgrades: Buy
Price Target: $75
Current: $108.91
Upside: -31.14%
Nov 1, 2021
Downgrades: Hold
Price Target: n/a
Current: $48.79
Upside: -
Nov 1, 2021
Upgrades: Buy
Price Target: $110
Current: $76.25
Upside: +44.26%
Aug 27, 2021
Maintains: Buy
Price Target: $150 → $165
Current: $83.74
Upside: +97.04%
Aug 2, 2021
Downgrades: Hold
Price Target: n/a
Current: $6.87
Upside: -
Jun 18, 2021
Maintains: Buy
Price Target: $110 → $123
Current: $48.61
Upside: +152.01%
Apr 12, 2021
Downgrades: Hold
Price Target: n/a
Current: $71.93
Upside: -
Mar 10, 2021
Downgrades: Hold
Price Target: n/a
Current: $116.70
Upside: -
Mar 27, 2020
Reiterates: Buy
Price Target: $165 → $155
Current: $155.40
Upside: -0.26%